Clinical Trial Update: Study of DISC-0974-201 in Participants With IBD and Anemia [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating DISC-0974-201 in inflammatory bowel disease and anemia is currently recruiting. The sponsor is Disc Medicine, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Inflammatory Bowel Disease

Drugs mentioned

• DISC-0974-201

Snippet

Sponsor: Disc Medicine, Inc | Conditions: Inflammatory Bowel Disease (IBD), Anemia | Phase 2 | Status: RECRUITING